Bristol-Myers Extends License for Genome Therapeutics Database

genomeweb
360dx

Bristol-Myers Extends License for Genome Therapeutics Database

Dec 06, 2000

NEW YORK, Dec 6 - Genome Therapeutics said Wednesday that Bristol-Myers Squibb had renewed its license for the PathoGenome database, extending a subscription that began in 1997.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Studies Explore Genetic Alterations Linked to Aggressive, Metastatic Prostate Cancer
Genomic Study Points to Stability in Enteric Fever-Causing Salmonella Lineage
Genomes Confirm Food Industry Yeast Belongs to Same Species as Opportunistic Pathogen
Danaher Q2 Revenues Rise 10 Percent, Beating Analyst Estimates
Garvan Institute's Australian Genomic Cancer Medicine Program Receives A$50M in Government Funding
VA, IBM Watson Extend Precision Oncology Partnership

The Scan

Building Up Numbers

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

Slow Coverage

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

Many Choices

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

This Week in Nature

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.

Main menu